Navigation Links
MannKind Corporation to Review Positive Results From Final Two Pivotal Phase 3 Clinical Studies in Type 1 and Type 2 Diabetes
Date:12/15/2008

Live Broadcast on December 18, 2008 at 9 a.m. Eastern Time

VALENCIA, Calif., Dec. 15 /PRNewswire-FirstCall/ --MannKind Corporation (Nasdaq: MNKD) will host a live broadcast to review clinical results from its final two Phase 3 studies of AFRESA(TM), the company's ultra rapid acting, inhaled insulin product, at 9 a.m. Eastern Time on Thursday, December 18, 2008.

To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in viewing the live webcast via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.

A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 873-5860 or (203) 369-3996. A replay will also be available on MannKind's website for fourteen days.

About AFRESA

Afresa is an ultra rapid acting inhaled insulin product that has completed Phase 3 trials. The pharmacokinetic profile of Afresa sets it apart from all other insulin products. The large surface area of the lung provides unique access to the circulatory system. The pH-sensitive Afresa particles immediately dissolve upon contact with the lung surface, releasing insulin monomers that rapidly enter the bloodstream. It achieves peak insulin levels within 12-14 minutes of administration, effectively mimicking the release of meal-time insulin observed in healthy individuals, but which is absent from patients with diabetes.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercializatio
'/>"/>

SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. MannKind Reports Positive Data from a Phase 3 Clinical Study of Technosphere Insulin in Type 1 Diabetes
2. MannKind Addresses Pfizers Announcement Regarding Exubera
3. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
4. Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
5. Chemstar Corporation Announces a New Powerful, One-Step Product That Effectively Controls Listeria, Salmonella, E. coli and Fly Larvae in Floor Drains
6. Successful Results for Mymetics Corporations Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
7. National Jewish Health and Roche Diagnostics Corporation Reach Agreement to Pursue Environmental Molecular Diagnostics Opportunities
8. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
9. Genaera Corporation Presents Data on Mechanism of Inhibition of PTP-1B for Trodusquemine (MSI-1436) at Federation of American Societies for Experimental Biology (FASEB) Meeting
10. Genaera Corporation Presents Additional Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at American Diabetes Association
11. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... -- Shire plc (LSE: SHP, NASDAQ: ... Fair Trading (OFT) approval condition to the announced tender offer ... VPHM).   As a result of the waiver, ... Shire expects to complete the tender offer on January 24, ... satisfaction of all of the remaining conditions to the tender ...
(Date:1/15/2014)... 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was ... in which he has overseen the company,s four facilities ... , and Costa Rica.  Mr. King joined Tegra ... sales, engineering and manufacturing experience in medical device businesses, ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... market research report is available in its ... Market & Forecast – Worldwide Analysis ... Insulin Pump Market Analysis ... in the market as insulin delivery systems ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
(Date:4/14/2014)... COLUMBUS, Ohio Heart patients with beliefs about health ... to skip sessions of cardiac rehabilitation, new research suggests. ... number of these beliefs referred to as "irrational ... was associated with lower adherence to a prescribed ... assessed: Doubting the preventive power of the flu vaccine ...
(Date:4/14/2014)... A new study shows that domestic abuse is ... depression and post-traumatic stress disorder (PTSD), in mothers. ... abuse are associated with specific mental health problems. ... Carolina State University, Simon Fraser University and the ... see whether and how intimate partner abuse ...
(Date:4/14/2014)... to treatment guidelines for high-risk bladder cancer, chemotherapy ... in routine clinical practice. The findings are published ... journal of the American Cancer Society. , Clinical ... patients with muscle-invasive bladder cancer who are given ... whether chemotherapy after surgery also improves survival. To ...
(Date:4/13/2014)... force has created a new definition for epilepsy that ... disease. The study published in Epilepsia , a ... League Against Epilepsy (ILAE), provides a greater level of ... unprovoked seizures, and those with one unprovoked seizure and ... , The 2005 report by the ILAE task force ...
(Date:4/11/2014)... there is still no effective medical treatment. In an ... of a schizophrenic person, researchers from the University of ... rats that have been given hallucinogenic drugs. This may ... Seven per cent of the adult population suffers from ... understand the disease, they still do not know what ...
Breaking Medicine News(10 mins):Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:New clinical definition for epilepsy improves diagnosis accuracy 2Health News:Protein researches closing in on the mystery of schizophrenia 2Health News:Protein researches closing in on the mystery of schizophrenia 3
... say , WEDNESDAY, Nov. 14 (HealthDay News) -- U.S. scientists ... in cancer cells. , They found that genes in cancer ... structures called nucleosomes within the cells. , "The study shows ... in cancer cells. It identifies what the target looks like, ...
... other partners and donors share in success, ... National,Pediatric Brain Tumor Consortium headquarters, Chili,s Care ... for exceptional patient care, MEMPHIS, Tenn., Nov. ... Grill & Bar(R) celebrated the national,grand opening of ...
... Toy Drive to Benefit Shands Jacksonville-Marks Grand Opening ... Bank will,officially dedicate its new Mandarin branch today ... will attend the,grand opening event this morning, which ... opening of the facility and the,Company,s expanded presence ...
... With half of dogs and cats over age 10 dying of cancer, ... free oncology consultations ... any pet., BOISE, Idaho, Nov. 14 When Jack Stephens, DVM, ... emotional support from his small dog, Spanky. Recognizing that,cancer now claims the ...
... Be Held in Conjunction with Inaugural Gala, NORTH ... the National Patient Safety Foundation today announced that it ... 7-8, 2008 in,Boston, Massachusetts. The Institute, established by NPSF ... strategic paths and calls to action for,the field of ...
... initials? Most people do and, as past research has shown, ... For example, Jack is more likely to move to Jacksonville ... to move to Philadelphia and marry Phyllis. Scientists call this ... enough to encourage the pursuit of name-resembling life outcomes and ...
Cached Medicine News:Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 2Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 2Health News:All Pets With Cancer in U.S. Provided Free Consultation 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 4Health News:Lucian Leape Institute Announces First Roundtable 2Health News:Lucian Leape Institute Announces First Roundtable 3Health News:What's in a name? Initials linked to success, study shows 2
... accommodate a variety of applications across a ... DestinyPlus is suitable for any laboratory demanding ... a mixed-mode throughput exceeding 95 PT/aPTT/Fibrinogen per ... full range of chromogenics, the AMAX DestinyPlus ...
Non-invasive and continuous tcpCO2 and tcpO2 patient monitoring....
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2....
... components that comprise the SmartPill GI ... comprise the SmartPill GI Monitoring System: ... Receiver software and SmartPill MotiliGI software. ... indispensable parts of the SmartPill GI ...
Medicine Products: